Literature DB >> 28211814

Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations.

Jack C de la Torre.   

Abstract

There is growing evidence that chronic brain hypoperfusion plays a central role in the development of Alzheimer's disease (AD) long before dyscognitive symptoms or amyloid-β accumulation in the brain appear. This commentary proposes that dementia with Lewy bodies (DLB), frontotemporal dementia (FTD), and Creutzfeldt-Jakob disease (CJD) may also develop from chronic brain hypoperfusion following a similar but not identical neurometabolic breakdown as AD. The argument to support this conclusion is that chronic brain hypoperfusion, which is found at the early stages of the three dementias reviewed here, will reduce oxygen delivery and lower oxidative phosphorylation promoting a steady decline in the synthesis of the cell energy fuel adenosine triphosphate (ATP). This process is known to lead to oxidative stress. Virtually all neurodegenerative diseases, including FTD, DLB, and CJD, are characterized by oxidative stress that promotes inclusion bodies which differ in structure, location, and origin, as well as which neurological disorder they typify. Inclusion bodies have one thing in common; they are known to diminish autophagic activity, the protective intracellular degradative process that removes malformed proteins, protein aggregates, and damaged subcellular organelles that can disrupt neuronal homeostasis. Neurons are dependent on autophagy for their normal function and survival. When autophagic activity is diminished or impaired in neurons, high levels of unfolded or misfolded proteins overwhelm and downregulate the neuroprotective activity of unfolded protein response which is unable to get rid of dysfunctional organelles such as damaged mitochondria and malformed proteins at the synapse. The endpoint of this neuropathologic process results in damaged synapses, impaired neurotransmission, cognitive decline, and dementia.

Entities:  

Keywords:  Alzheimer’s disease; Creutzfeldt-Jakob disease; autophagy; brain hypoperfusion; cerebral blood flow; cognitive decline; dementia with Lewy bodies; frontotemporal dementia; inclusion bodies; prion; protein misfolding; unfolded protein response

Mesh:

Year:  2017        PMID: 28211814     DOI: 10.3233/JAD-161266

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  20 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 2.  The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

3.  A longitudinal characterization of perfusion in the aging brain and associations with cognition and neural structure.

Authors:  Adam M Staffaroni; Yann Cobigo; Fanny M Elahi; Kaitlin B Casaletto; Samantha M Walters; Amy Wolf; Cutter A Lindbergh; Howard J Rosen; Joel H Kramer
Journal:  Hum Brain Mapp       Date:  2019-05-07       Impact factor: 5.038

4.  Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion.

Authors:  Sai Sampath Thammisetty; Laurence Renaud; Vincent Picher-Martel; Yuan Cheng Weng; Frédéric Calon; Stephan Saikali; Jean-Pierre Julien; Jasna Kriz
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

Review 5.  Effects of Hypertension on Alzheimer's Disease and Related Disorders.

Authors:  Joseph E Malone; Mohamed I Elkasaby; Alan J Lerner
Journal:  Curr Hypertens Rep       Date:  2022-09-20       Impact factor: 4.592

6.  Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease.

Authors:  Anna Csiszar; Stefano Tarantini; Gábor A Fülöp; Tamas Kiss; M Noa Valcarcel-Ares; Veronica Galvan; Zoltan Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2017-08-29       Impact factor: 7.713

Review 7.  The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer's disease.

Authors:  Alessandro Galgani; Filippo Sean Giorgi; Stefano Puglisi-Allegra; Carla Letizia Busceti; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2021-05-03       Impact factor: 3.575

Review 8.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Authors:  Stephen C Cunnane; Mark J Millan; Eugenia Trushina; Cecilie Morland; Alessandro Prigione; Gemma Casadesus; Zane B Andrews; M Flint Beal; Linda H Bergersen; Roberta D Brinton; Suzanne de la Monte; Anne Eckert; Jenni Harvey; Ross Jeggo; Jack H Jhamandas; Oliver Kann; Clothide Mannoury la Cour; William F Martin; Gilles Mithieux; Paula I Moreira; Michael P Murphy; Klaus-Armin Nave; Tal Nuriel; Stéphane H R Oliet; Frédéric Saudou; Mark P Mattson; Russell H Swerdlow
Journal:  Nat Rev Drug Discov       Date:  2020-07-24       Impact factor: 84.694

Review 9.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

Review 10.  Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.

Authors:  Elena A Kosenko; Lyudmila A Tikhonova; Carmina Montoliu; George E Barreto; Gjumrakch Aliev; Yury G Kaminsky
Journal:  Front Neurosci       Date:  2018-01-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.